Comparison of Clinical Outcomes of Intravitreal Bevacizumab and Aflibercept in Type 1 Prethreshold Retinopathy of Prematurity in Posterior Zone II

PURPOSE: To evaluate the efficacy and safety of intravitreal injection (IVI) of bevacizumab (IVB) versus aflibercept (IVA) in premature infants with type 1 prethreshold retinopathy of prematurity (ROP) in the posterior Zone II. METHODS: The study was a multicenter, historical cohort of premature new...

Descripción completa

Detalles Bibliográficos
Autores principales: Eftekhari Milani, Amir, Bagheri, Masood, Niyousha, Mohamad Reza, Rezaei, Leila, Hazeri, Somayyeh, Safarpoor, Samad, Abdollahi, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128430/
https://www.ncbi.nlm.nih.gov/pubmed/35620366
http://dx.doi.org/10.4103/joco.joco_193_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128430/
https://www.ncbi.nlm.nih.gov/pubmed/35620366
http://dx.doi.org/10.4103/joco.joco_193_21

Ejemplares similares